Stereotaxis, Inc.

STXS NYSE CIK: 0001289340

Company Information

Industry Electromedical & Electrotherapeutic Apparatus
SIC Code 3845
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 710 N TUCKER BLVD, ST.LOUIS, MO, 63101
Mailing Address 710 N TUCKER BLVD, ST.LOUIS, MO, 63101
Phone 314-678-6100
Fiscal Year End 1231
EIN 943120386

Recent SEC Filings

Form Type Date Filed Document
DEF 14A Definitive proxy statement April 3, 2026 View on SEC
10-K/A Annual report amendment April 3, 2026 View on SEC
S-3 Shelf registration for future offerings March 13, 2026 View on SEC
10-K Annual financial report March 12, 2026 View on SEC
8-K Current report of material events March 9, 2026 View on SEC
4 Insider stock transaction report January 2, 2026 View on SEC
4 Insider stock transaction report January 2, 2026 View on SEC
4 Insider stock transaction report January 2, 2026 View on SEC
4 Insider stock transaction report January 2, 2026 View on SEC
4 Insider stock transaction report January 2, 2026 View on SEC

Annual Reports

10-K March 12, 2026
  • Pioneering robotic magnetic navigation systems for complex arrhythmia treatment.
  • Achieved 5% revenue growth to $34.5 million in 2025, driven by recurring revenue.
View Analysis

Related Companies

Companies in the same industry (SIC: 3845)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.